Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Arcadia Biosciences, Inc.RKDA · Entity 8593 | Director | September 10, 2026 | September 14, 2026 |
| ENDOLOGIX INC /DE/ELGX · Entity 146591 | Director | August 12, 2020 | August 14, 2020 |
| Nuwellis, Inc.NUWE · Entity 8478 | Director | April 28, 2026 | April 30, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Arcadia Biosciences, Inc.
Report date September 10, 2026 · Filed September 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.46 · Expires 2036-09-10 | Direct | 23,338 |
Reported balance
After 2026-09-10 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-10 · Grant · Acquired 10,000 · Balance 23,338 F1: The Option will become 100% vested and exercisable on the earlier to occur of (i) September 10, 2027 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service. |
Filing footnotes · ownership attribution and instrument terms
F1: The Option will become 100% vested and exercisable on the earlier to occur of (i) September 10, 2027 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service.
ENDOLOGIX INC /DE/
Report date August 12, 2020 · Filed August 14, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 710 |
Reported balance
After 2020-08-12 transaction · row 1
1 source rowRow 1 · 2020-08-12 · Sale · Disposed 28,630 · Balance 710 |
Nuwellis, Inc.
Report date April 28, 2026 · Filed April 30, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Nonstatutory Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.16 · Expires 2036-04-27 | Direct | 6,744 |
Reported balance
After 2026-04-28 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-04-28 · Grant · Acquired 6,744 · Balance 6,744 F1: Vests in 12 approximately equal consecutive monthly increments, commencing on the one-month anniversary of the date of grant, so that all of the options will be vested on the one-year anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Vests in 12 approximately equal consecutive monthly increments, commencing on the one-month anniversary of the date of grant, so that all of the options will be vested on the one-year anniversary of the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 10, 2026 Filed Sep 14, 2026 20:02 UTC | Arcadia Biosciences, Inc. RKDA · Entity 8593 | GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $0.46 | $0.00 |
DisclosureSEC source: 0001193125-26-390521 · ownership.xml · derivative · entry 1 WALLER GREGORY D · CIK 0001204144 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,338 Underlying: Common Stock · 10,000 shares Expires 2036-09-10 F1 · derivative.exercise_date: The Option will become 100% vested and exercisable on the earlier to occur of (i) September 10, 2027 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service. Read SEC document |
| April 28, 2026 Filed Apr 30, 2026 01:12 UTC | Nuwellis, Inc. NUWE · Entity 8478 | GrantNonstatutory Stock Option (right to buy) · Derivative | 6,744 | $0.00 Strike: $1.16 | $0.00 |
DisclosureSEC source: 0001140361-26-017926 · form4.xml · derivative · entry 1 WALLER GREGORY D · CIK 0001204144 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,744 Underlying: Common Stock · 6,744 shares Expires 2036-04-27 F1 · derivative.exercise_date: Vests in 12 approximately equal consecutive monthly increments, commencing on the one-month anniversary of the date of grant, so that all of the options will be vested on the one-year anniversary of the date of grant. Read SEC document |
| May 20, 2025 Filed May 21, 2025 20:31 UTC | Nuwellis, Inc. NUWE · Entity 8478 | GrantNonstatutory Stock Option (right to buy) · Derivative | 17,496 | $0.00 Strike: $0.96 | $0.00 |
DisclosureSEC source: 0001140361-25-020056 · form4.xml · derivative · entry 1 WALLER GREGORY D · CIK 0001204144 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,496 Underlying: Common Stock · 17,496 shares Expires 2035-05-19 F1 · derivative.exercise_date: Vests in 12 approximately equal consecutive monthly increments, commencing on the one-month anniversary of the date of grant, so that all of the options will be vested on the one-year anniversary of the date of grant. Read SEC document |
| August 19, 2024 Filed Aug 21, 2024 23:32 UTC | Arcadia Biosciences, Inc. RKDA · Entity 8593 | GrantStock Option (Right to Buy) · Derivative | 10,909 | $0.00 Strike: $2.71 | $0.00 |
DisclosureSEC source: 0000950170-24-099639 · ownership.xml · derivative · entry 1 WALLER GREGORY D · CIK 0001204144 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,338 Underlying: Common Stock · 10,909 shares Expires 2034-08-19 F1 · derivative.exercise_date: The Option will become 100% vested and exercisable on the earlier to occur of (i) August 19, 2025 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service. Read SEC document |
| June 06, 2023 Filed Jun 16, 2023 16:59 UTC | Arcadia Biosciences, Inc. RKDA · Entity 8593 | GrantStock Option (Right to Buy) · Derivative | 937 | $0.00 Strike: $4.80 | $0.00 |
DisclosureSEC source: 0001209191-23-037752 · doc4.xml · derivative · entry 1 WALLER GREGORY D · CIK 0001204144 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,429 Underlying: Common Stock · 937 shares Expires 2033-06-06 F1 · derivative.exercise_date: The Option will become 100% vested and exercisable on the earlier to occur of (i) June 6, 2024 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service. Read SEC document |
| May 19, 2023 Filed May 23, 2023 20:18 UTC | Nuwellis, Inc. NUWE · Entity 8478 | GrantNonstatutory Stock Option (right to buy) · Derivative | 2,146 | $0.00 Strike: $3.02 | $0.00 |
DisclosureSEC source: 0001140361-23-026244 · form4.xml · derivative · entry 1 WALLER GREGORY D · CIK 0001204144 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,146 Underlying: Common Stock · 2,146 shares Expires 2033-05-18 F1 · derivative.exercise_date: Vests in 12 approximately equal consecutive monthly increments, commencing on the one-month anniversary of the date of grant, so that all of the options will be vested on the one-year anniversary of the date of grant. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 18:25 UTC | Arcadia Biosciences, Inc. RKDA · Entity 8593 | GrantStock Option (right to buy) · Derivative | 23,620 | $0.00 Strike: $1.34 | $0.00 |
DisclosureSEC source: 0001209191-22-033912 · doc4.xml · derivative · entry 1 WALLER GREGORY D · CIK 0001204144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,777 Underlying: Common Stock · 23,620 shares Expires 2032-06-01 F1 · derivative.exercise_date: The Option will become 100% vested and exercisable on the earlier to occur of (i) June 1, 2023 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service. Read SEC document |
| May 25, 2022 Filed May 26, 2022 20:40 UTC | Nuwellis, Inc. NUWE · Entity 8478 | GrantNonstatutory Stock Option (right to buy) · Derivative | 15,806 | $0.00 Strike: $0.62 | $0.00 |
DisclosureSEC source: 0001596771-22-000015 · primary_doc.xml · derivative · entry 1 WALLER GREGORY D · CIK 0001204144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,806 Underlying: Common Stock · 15,806 shares Expires 2032-05-24 F1 · derivative.exercise_date: Vests in 12 approximately equal consecutive monthly increments, commencing on the one-month anniversary of the date of grant, so that all of the options will be vested on the one-year anniversary of the date of grant. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 19:59 UTC | Arcadia Biosciences, Inc. RKDA · Entity 8593 | GrantStock Option (right to buy) · Derivative | 10,935 | $0.00 Strike: $2.89 | $0.00 |
DisclosureSEC source: 0001209191-21-038167 · doc4.xml · derivative · entry 1 WALLER GREGORY D · CIK 0001204144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,157 Underlying: Common Stock · 10,935 shares Expires 2031-06-02 F1 · derivative.exercise_date: The Option will become 100% vested and exercisable on the earlier to occur of (i) June 2, 2022 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service. Read SEC document |
| May 19, 2021 Filed May 20, 2021 21:02 UTC | Nuwellis, Inc. NUWE · Entity 8478 | GrantNonstatutory Stock Option (right to buy) · Derivative | 9,798 | $0.00 Strike: $3.63 | $0.00 |
DisclosureSEC source: 0001596771-21-000035 · primary_doc.xml · derivative · entry 1 WALLER GREGORY D · CIK 0001204144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,798 Underlying: Common Stock · 9,798 shares Expires 2031-05-18 F1 · derivative.exercise_date: Vests in 12 approximately equal consecutive monthly increments, commencing on the one-month anniversary of the date of grant, so that all of the options will be vested on the one-year anniversary of the date of grant. Read SEC document |
| August 12, 2020 Filed Aug 14, 2020 20:04 UTC | ENDOLOGIX INC /DE/ ELGX · Entity 146591 | SaleCommon Stock | 28,630 | $0.08 | $2,402.06 |
DisclosureSEC source: 0001013606-20-000171 · wf-form4_159744983627502.xml · nonDerivative · entry 1 WALLER GREGORY D · CIK 0001204144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 710 Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 15:09 UTC | Arcadia Biosciences, Inc. RKDA · Entity 8593 | GrantStock Option (right to buy) · Derivative | 9,137 | $0.00 Strike: $3.69 | $0.00 |
DisclosureSEC source: 0001209191-20-033824 · doc4.xml · derivative · entry 1 WALLER GREGORY D · CIK 0001204144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,222 Underlying: Common Stock · 9,137 shares Expires 2030-06-01 F1 · derivative.exercise_date: The Option will become 100% vested and exercisable on the earlier to occur of (i) June 1, 2021 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service. Read SEC document |
| May 20, 2020 Filed May 23, 2020 00:33 UTC | Nuwellis, Inc. CHFS · Entity 8478 | GrantNonstatutory Stock Option · Derivative | 18,849 | $0.00 Strike: $0.35 | $0.00 |
DisclosureSEC source: 0001567619-20-011105 · doc1.xml · derivative · entry 1 WALLER GREGORY D · CIK 0001204144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,849 Underlying: Common Stock · 18,849 shares Expires 2030-05-19 F1 · derivative.exercise_date: Vests in 12 approximately equal consecutive monthly increments, commencing on the one-month anniversary of the date of grant, so that all of the options will be vested on the one-year anniversary of the date of grant. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 19:16 UTC | ENDOLOGIX INC /DE/ ELGX · Entity 146591 | SaleCommon Stock | 582 | $3.00 | $1,746.00 |
DisclosureSEC source: 0001013606-19-000192 · wf-form4_157369057329527.xml · nonDerivative · entry 1 WALLER GREGORY D · CIK 0001204144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,340 Read SEC document |
| August 14, 2019 Filed Aug 15, 2019 20:23 UTC | ENDOLOGIX INC /DE/ ELGX · Entity 146591 | SaleCommon Stock | 715 | $6.61 | $4,726.15 |
DisclosureSEC source: 0001013606-19-000156 · wf-form4_156591501806304.xml · nonDerivative · entry 1 WALLER GREGORY D · CIK 0001204144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,922 Read SEC document |
| August 05, 2019 Filed Aug 6, 2019 17:15 UTC | ENDOLOGIX INC /DE/ ELGX · Entity 146591 | GrantOption to Purchase · Derivative | 9,023 | $6.67 Strike: $6.67 | $60,183.41 |
DisclosureSEC source: 0001013606-19-000133 · wf-form4_156512613589456.xml · derivative · entry 2 WALLER GREGORY D · CIK 0001204144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,023 Underlying: Common Stock · 9,023 shares Expires 2029-08-05 F2 · shares: 100% of the option award shall vest on August 5, 2020. Read SEC document |
| August 05, 2019 Filed Aug 6, 2019 17:15 UTC | ENDOLOGIX INC /DE/ ELGX · Entity 146591 | GrantCommon Stock | 13,494 | $0.00 | $0.00 |
DisclosureSEC source: 0001013606-19-000133 · wf-form4_156512613589456.xml · nonDerivative · entry 1 WALLER GREGORY D · CIK 0001204144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,637 F1 · shares: 100% of the time-based restricted stock unit award shall vest on August 5, 2020 and shall settle in shares of common stock. Read SEC document |
| June 03, 2019 Filed Jun 5, 2019 00:04 UTC | Arcadia Biosciences, Inc. RKDA · Entity 8593 | GrantStock Option (right to buy) · Derivative | 6,912 | $0.00 Strike: $5.04 | $0.00 |
DisclosureSEC source: 0001209191-19-034598 · doc4.xml · derivative · entry 1 WALLER GREGORY D · CIK 0001204144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,085 Underlying: Common Stock · 6,912 shares Expires 2029-06-03 F1 · derivative.exercise_date: The Option will become 100% vested and exercisable on the earlier to occur of (i) June 3, 2020 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service. Read SEC document |
| May 23, 2019 Filed May 28, 2019 21:02 UTC | Nuwellis, Inc. CHFS · Entity 8478 | GrantNonstatutory Stock Option (right to buy) · Derivative | 1,970 | $0.00 Strike: $3.42 | $0.00 |
DisclosureSEC source: 0001596771-19-000052 · primary_doc.xml · derivative · entry 1 WALLER GREGORY D · CIK 0001204144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,970 Underlying: Common Stock · 1,970 shares Expires 2029-05-22 F1 · derivative.exercise_date: Vests in 12 approximately equal consecutive monthly increments, commencing on the one-month anniversary of the date of grant, so that all of the options will be vested on the one-year anniversary of the date of grant. Read SEC document |
| December 30, 2018 Filed Jan 2, 2019 20:23 UTC | ENDOLOGIX INC /DE/ ELGX · Entity 146591 | GrantCommon Stock | 120,887 | $0.00 | $0.00 |
DisclosureSEC source: 0001013606-19-000020 · wf-form4_154647856852281.xml · nonDerivative · entry 1 WALLER GREGORY D · CIK 0001204144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,437 F1 · kind: 100% of the time-based restricted stock unit award shall vest on December 30, 2019 and shall settle in shares of common stock. Read SEC document |
| August 10, 2018 Filed Aug 13, 2018 20:14 UTC | Nuwellis, Inc. CHFS · Entity 8478 | SaleCommon Stock | 72 | $1.03 | $74.43 |
DisclosureSEC source: 0001596771-18-000088 · primary_doc.xml · nonDerivative · entry 1 WALLER GREGORY D · CIK 0001204144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2 F1 · balance_after: On January 12, 2017, the Issuer effected a 1-for-30 reverse stock split of the issued and outstanding shares of its common stock; upon effectiveness of the reverse stock split, every 30 shares of common stock was automatically converted into one share of common stock. On October 12, 2017, the Issuer effected a 1-for-20 reverse stock split of the issued and outstanding shares of its common stock; upon effectiveness of the reverse stock split, every 20 shares of common stock was automatically converted into one share of common stock. Read SEC document |
| June 06, 2018 Filed Jun 8, 2018 23:54 UTC | Arcadia Biosciences, Inc. RKDA · Entity 8593 | GrantStock Option (right to buy) · Derivative | 3,204 | $0.00 Strike: $10.80 | $0.00 |
DisclosureSEC source: 0001209191-18-036805 · doc4.xml · derivative · entry 1 WALLER GREGORY D · CIK 0001204144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,173 Underlying: Common Stock · 3,204 shares Expires 2028-06-06 F1 · derivative.exercise_date: The Option will become 100% vested and excercisable on the earlier to occur of (i) June 6, 2019 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service. Read SEC document |
| May 25, 2018 Filed May 29, 2018 20:58 UTC | Nuwellis, Inc. CHFS · Entity 8478 | GrantNonstatutory Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $3.01 | $0.00 |
DisclosureSEC source: 0001596771-18-000066 · primary_doc.xml · derivative · entry 1 WALLER GREGORY D · CIK 0001204144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2028-05-24 F1 · derivative.exercise_date: Vests in 12 approximately equal consecutive monthly increments, commencing on the one-month anniversary of the date of grant, so that all of the options will be vested on the one-year anniversary of the date of grant. Read SEC document |
| January 17, 2018 Filed Jan 19, 2018 21:50 UTC | Nuwellis, Inc. CHFS · Entity 8478 | GrantNonstatutory Stock Option (right to buy) · Derivative | 52,807 | $0.00 Strike: $3.55 | $0.00 |
DisclosureSEC source: 0001596771-18-000007 · primary_doc.xml · derivative · entry 1 WALLER GREGORY D · CIK 0001204144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,807 Underlying: Common Stock · 52,807 shares Expires 2028-01-16 F1 · derivative.exercise_date: Vests in 12 approximately equal consecutive monthly increments, commencing on the one-month anniversary of the date of grant, so that all of the options will be vested on the one-year anniversary of the date of grant. Read SEC document |
| June 07, 2017 Filed Jun 9, 2017 21:52 UTC | Arcadia Biosciences, Inc. RKDA · Entity 8593 | GrantStock Option (right to buy) · Derivative | 119,377 | $0.00 Strike: $0.73 | $0.00 |
DisclosureSEC source: 0001209191-17-038961 · doc4.xml · derivative · entry 1 WALLER GREGORY D · CIK 0001204144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,377 Underlying: Common Stock · 119,377 shares Expires 2027-06-07 F1 · shares: The shares subject to the Option shall vest and become exercisable in three (3) equal annual installments, with one-third of the shares subject to the Option vesting on each of the first three (3) anniversaries of the date of the award, subject to the Participant's continued service through each applicable vesting date. Read SEC document |
| June 02, 2017 Filed Jun 6, 2017 20:48 UTC | Nuwellis, Inc. CHFS · Entity 8478 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 8,000 | $0.00 Strike: $0.57 | $0.00 |
DisclosureSEC source: 0001596771-17-000053 · primary_doc.xml · derivative · entry 1 WALLER GREGORY D · CIK 0001204144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2027-06-01 F1 · derivative.exercise_date: Vests in 12 approximately equal consecutive monthly increments, commencing on the one-month anniversary of the date of grant, so that all of the options will be vested on the one-year anniversary of the date of grant. Read SEC document |
| May 31, 2017 Filed Jun 2, 2017 12:22 UTC | ENDOLOGIX INC /DE/ ELGX · Entity 146591 | GrantCommon Stock | 22,822 | $0.00 | $0.00 |
DisclosureSEC source: 0001013606-17-000081 · wf-form4_149642050791464.xml · nonDerivative · entry 1 WALLER GREGORY D · CIK 0001204144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,550 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.